.png)
Vitamin D, a fat-soluble secosteroid, plays a vital role in calcium homeostasis and bone metabolism. The global Vitamin D market serves industries such as pharmaceuticals, dietary supplements, food & beverages, and cosmetics. In 2025, the Vitamin D market shows robust expansion driven by increased health awareness and preventive healthcare spending.
Vitamin D market stood at USD 3,136.99 million in 2023 and is expected to reach USD 3,463.87 million by 2024, ultimately rising to USD 7,654.96 million by 2032, with a CAGR of 10.42% during the forecast period from 2024 to 2032
How Big is the Vitamin D Industry in 2025?
The global Vitamin D industry in 2025 is exhibiting substantial growth, driven by increasing health awareness, aging demographics, and the rising prevalence of Vitamin D deficiency. In 2025, the global Vitamin D market is segmented across dietary supplements (46%), pharmaceuticals (29%), food and beverage fortification (16%), and cosmetics (9%).
Regionally, the market distribution reflects North America holding the largest share at 34%, followed by Asia-Pacific with 31%, Europe at 28%, and the Rest of the World accounting for the remaining 7%. Within North America, the U.S. dominates with 91% of the regional share, driven by over 72% of adults consuming Vitamin D supplements and more than 40% of fortified food products containing Vitamin D3.
In Europe, Germany and the U.K. contribute a combined 53% to the region's market share, reflecting a strong uptake in elder care supplements and infant nutrition. In Asia-Pacific, China and India collectively represent 61% of the regional demand, with urban Chinese consumers accounting for 72% of Vitamin D product sales due to awareness campaigns and e-commerce penetration.
Over 68% of the global elderly population (aged 60+) is reported to have insufficient Vitamin D levels, directly fueling demand in both over-the-counter and prescription categories. Additionally, approximately 47% of pediatricians worldwide now routinely recommend Vitamin D supplementation for infants and children.
Overall, the Vitamin D industry in 2025 stands as a high-demand, health-critical sector, underpinned by robust demographic trends and supported by public health policy endorsements across key global regions.
USA Growing Vitamin D Market
In the United States, 61% of dietary supplement sales include Vitamin D-based formulations. The region shows a higher prevalence of vitamin D deficiency due to sedentary lifestyles and limited sun exposure in urban areas. Retail pharmacies and eCommerce channels are significantly driving supplement purchases.
Vitamin D Market: Regional Insights
The global Vitamin D market in 2025 is marked by regional variations driven by climate, dietary habits, regulatory mandates, and public health initiatives. North America leads with 34% of the global market share. The United States dominates this region, accounting for 91% of North America’s Vitamin D demand. Within the U.S., over 72% of adults report using Vitamin D supplements, while fortified food products represent 43% of total Vitamin D intake. Canada contributes the remaining 9% of North America’s market, with 54% of its adult population using supplements in winter.
Asia-Pacific follows closely with 31% of global market share. China and India together represent 61% of APAC’s Vitamin D demand. In China,72% of total sales originate from urban centers, driven by preventive health trends and e-commerce platforms. In India, Vitamin D prescription rates have grown by 38% since 2020, with Tier 1 cities accounting for 57% of total consumption.
Europe commands a 28% share, led by Germany (26%) and the UK (27%) within the region. Nearly 49% of individuals over age 50 in Germany consume Vitamin D regularly. France and Italy collectively contribute 26%, with growing demand in functional foods and elderly care.
The Rest of the World represents >7%, with Latin America and the Middle East emerging as growth zones. Brazil accounts for 41% of Latin America’s market, and in South Africa, 33% of adults are diagnosed with Vitamin D deficiency, prompting increased supplement uptake.
Global Growth Insights unveils the top List global Vitamin D Companies:
| Company Name | Headquarters | CAGR (Past Year) | Revenue (Past Year) |
|---|---|---|---|
| Sichuan Neijiang Huixin Pharmacy CO. Ltd. | China | 6.2% | $56 million |
| Tocris Bioscience | UK | 4.8% | $40 million |
| DSM | Netherlands | 5.9% | $12.3 billion (Nutrition Segment) |
| Zhejiang NHU Co. Ltd. | China | 7.1% | $1.6 billion |
| Lycored | Israel | 5.2% | $145 million |
| Spectrum Chemical Manufacturing Corp. | USA | 3.9% | $80 million |
| NewGen Pharma | USA | 6.5% | $35 million |
| Divi’s Nutraceuticals | India | 8.0% | $280 million |
| Xiamen Kingdomway Group Company | China | 7.8% | $330 million |
| HangZhou Think Chemical Co., Ltd. | China | 6.7% | $92 million |
| Fermenta Biotech Limited | India | 4.9% | $50 million |
| McKinley Resources Inc. | USA | 5.1% | $18 million |
| Zhejiang Garden Biochemical High-Tech Co Ltd | China | 6.6% | $105 million |
| Adisseo | France | 6.0% | $1.5 billion |
| Dishman Group | India | 5.4% | $410 million |
| Vitablend | Netherlands | 4.7% | $25 million |
| Stabicoat Vitamins | USA | 3.8% | $12 million |
| Pharmavit | Netherlands | 4.9% | $37 million |
| BASF SE | Germany | 3.2% | $3.8 billion (Nutrition Segment) |
| Synthesia, a.s. | Czech Republic | 5.5% | $70 million |
Regional Opportunities in the Vitamin D Market
North America: Expansion of online health platforms; partnerships with wellness influencers Europe: Fortification mandates and nutrition labeling reforms Asia-Pacific: Growing urban middle-class; increase in pediatric supplement use Latin America & MEA: Government nutritional programs and maternal health campaigns
Conclusion: What is the Future of Vitamin D Companies?
Vitamin D companies are poised for growth driven by health awareness, digital health integration, and government support. Innovation in delivery formats (gummies, sprays, nano-encapsulated forms) is expected to diversify offerings and capture wider consumer demographics.
FAQ
1. Which Vitamin D company is the most diversified in terms of product range?
DSM and BASF SE offer broad portfolios across human nutrition, pharma-grade Vitamin D3, and animal health, giving investors a balanced exposure.
2. Which company has shown the fastest YoY growth?
Divi’s Nutraceuticals and Xiamen Kingdomway Group Company both posted over 7% growth in the last year, outperforming the segment average.
3. Which regions are most profitable for new Vitamin D entrants?
Asia-Pacific, especially India and China, due to fast-rising disposable income and low current supplementation penetration.
4. What investment risk should be considered?
Regulatory hurdles, especially in Europe and the U.S., where dosage and labeling are tightly monitored.